title: Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects.
abstract: BACKGROUND
  We have previously shown that in healthy young men, a less favorable body composition is associated with higher free triiodothyronine (fT3) levels within the euthyroid range. Besides, a higher free-triiodothyronine-to-free-thyroxin (fT3-to-fT4) ratio has been related to a less favorable metabolic phenotype and more placental growth in pregnant women. In the present study, we therefore investigated whether serum thyrotropin (TSH), thyroid hormone levels, and the fT3-to-fT4 ratio are associated with metabolic and adiposity-related cardiovascular risk markers in a healthy population of middle-aged euthyroid men and women.
  
  
  METHODS
  Thyroid parameters were measured in 2524 generally healthy subjects from the Asklepios Study (35-55 years, mean age 46 years). Analyses were restricted to 2315 subjects (1138 women and 1177 men), not using thyroid medication, not having anti-TPO levels above clinical cutoff values or TSH levels outside the reference range (0.27-4.2 mU/L). Twenty-seven percent of the women and 47.5% of the men were overweight, while 13% of women and 17% of men were obese. Twenty percent of the subjects were active smokers. Serum thyroid function parameters were determined by electrochemiluminescence.
  
  
  RESULTS
  fT3 and the fT3-to-fT4 ratio were positively related to body mass index (BMI), waist circumference, and components of metabolic syndrome, that is, triglycerides, systolic and diastolic blood pressure, and fasting plasma glucose, and negatively with HDL-cholesterol levels, whereas fT4 was negatively associated with BMI, waist circumference, and triglycerides (p<0.001). TSH related positively with total cholesterol levels (p<0.01), triglycerides, and systolic and diastolic blood pressure (p<0.001). The fT3-to-fT4 ratio was further positively associated with the adiposity-related inflammation markers interleukin-6 and high-sensitivity C-reactive protein and to pulse wave velocity. All associations were adjusted for sex, age, height, and smoking, and most associations persisted after additional adjustment for weight or waist circumference.
  
  
  CONCLUSIONS
  In healthy euthyroid middle-aged men and women, higher fT3 levels, lower fT4 levels, and thus a higher fT3-to-fT4 ratio are consistently associated with various markers of unfavorable metabolic profile and cardiovascular risk.
authors.affiliation: 1 Department of Endocrinology, Ghent University Hospital , Ghent, Belgium .
authors.forename: Greet L
authors.initials: GL
authors.lastname: Roef
authors.forename: Ernst R
authors.initials: ER
authors.lastname: Rietzschel
authors.forename: Caroline M
authors.initials: CM
authors.lastname: Van Daele
authors.forename: Youri E
authors.initials: YE
authors.lastname: Taes
authors.forename: Marc L
authors.initials: ML
authors.lastname: De Buyzere
authors.forename: Thierry C
authors.initials: TC
authors.lastname: Gillebert
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Kaufman
mesh_terms: D000328:Adult; D015992:Body Mass Index; D002097:C-Reactive Protein / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000209:etiology; D008076:Cholesterol, HDL / Q000097:blood; D006801:Humans; D015850:Interleukin-6 / Q000097:blood; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood*; D014280:Triglycerides / Q000097:blood; D014284:Triiodothyronine / Q000097:blood*; D055105:Waist Circumference; D055815:Young Adult
chemical_list: D008076:Cholesterol, HDL; D015850:Interleukin-6; D014280:Triglycerides; D014284:Triiodothyronine; D013972:Thyrotropin; D002097:C-Reactive Protein; D013974:Thyroxine
references.citation: Mol Cell Endocrinol. 2010 Mar 25;316(2):165-71
references.pmid: 19540303
references.citation: Clin Endocrinol (Oxf). 2009 Jan;70(1):152-60
references.pmid: 18494864
references.citation: Circulation. 2009 Oct 20;120(16):1640-5
references.pmid: 19805654
references.citation: Clin Endocrinol (Oxf). 2007 Aug;67(2):265-9
references.pmid: 17547687
references.citation: Thyroid. 2013 Aug;23(8):947-54
references.pmid: 23339744
references.citation: Eur J Cardiovasc Prev Rehabil. 2007 Apr;14(2):179-91
references.pmid: 17446795
references.citation: J Hypertens. 2012 Mar;30(3):592-9
references.pmid: 22227818
references.citation: J Hum Hypertens. 2010 Feb;24(2):134-8
references.pmid: 19554027
references.citation: J Clin Endocrinol Metab. 2004 Jul;89(7):3455-61
references.pmid: 15240631
references.citation: Clin Chem. 1974 Apr;20(4):470-5
references.pmid: 4818200
references.citation: Eur J Prev Cardiol. 2012 Aug;19(4):864-73
references.pmid: 21724680
references.citation: J Clin Endocrinol Metab. 2012 Feb;97(2):326-33
references.pmid: 22205712
references.citation: J Hypertens. 2008 Jul;26(7):1411-9
references.pmid: 18551018
references.citation: J Clin Endocrinol Metab. 2012 Mar;97(3):E414-8
references.pmid: 22238397
references.citation: Clin Endocrinol (Oxf). 2006 Feb;64(2):125-8
references.pmid: 16430708
references.citation: J Clin Endocrinol Metab. 2007 Mar;92(3):841-5
references.pmid: 17200168
references.citation: Ann Intern Med. 2000 Feb 15;132(4):270-8
references.pmid: 10681281
references.citation: Thyroid. 2007 Nov;17(11):1075-84
references.pmid: 17900236
references.citation: Med Clin North Am. 2012 Mar;96(2):269-81
references.pmid: 22443975
references.citation: Arch Intern Med. 2000 Jul 10;160(13):1993-9
references.pmid: 10888973
references.citation: Eur J Endocrinol. 2009 Sep;161(3):459-65
references.pmid: 19700640
references.citation: Atherosclerosis. 2009 Jun;204(2):e77-81
references.pmid: 18977482
references.citation: J Clin Endocrinol Metab. 2007 Feb;92(2):491-6
references.pmid: 17090642
references.citation: Endocr Metab Immune Disord Drug Targets. 2013 Mar;13(1):4-12
references.pmid: 23369133
references.citation: Korean J Intern Med. 2008 Jun;23(2):53-7
references.pmid: 18646506
references.citation: JAMA. 2006 Mar 1;295(9):1033-41
references.pmid: 16507804
references.citation: Thyroid. 2013 Aug;23(8):955-63
references.pmid: 23427935
references.citation: Horm Res. 2008;70(1):51-7
references.pmid: 18493150
references.citation: Eur J Endocrinol. 2012 Nov;167(5):719-26
references.pmid: 22956557
references.citation: Hypertension. 2007 Jun;49(6):1248-55
references.pmid: 17404183
references.citation: J Clin Endocrinol Metab. 2012 Aug;97(8):2724-31
references.pmid: 22730515
references.citation: J Korean Med Sci. 2011 Feb;26(2):243-9
references.pmid: 21286016
references.citation: J Clin Endocrinol Metab. 2012 Apr;97(4):E602-7
references.pmid: 22259052
references.citation: Arch Intern Med. 2008 Mar 24;168(6):587-92
references.pmid: 18362250
references.citation: J Cardiometab Syndr. 2007 Summer;2(3):198-206
references.pmid: 17786084
references.citation: Exp Clin Endocrinol Diabetes. 2011 Mar;119(3):144-50
references.pmid: 21086247
references.citation: Clin Endocrinol (Oxf). 2010 Mar;72(3):404-10
references.pmid: 19486022
references.citation: Am J Med. 1984 Jun;76(6):963-70
references.pmid: 6731468
references.citation: Physiol Res. 2010;59(4):561-569
references.pmid: 19929143
references.citation: Hypertension. 2008 Sep;52(3):535-41
references.pmid: 18663154
references.citation: Clin Endocrinol (Oxf). 2007 Nov;67(5):668-73
references.pmid: 17596198
references.citation: J Clin Invest. 2006 Oct;116(10):2571-9
references.pmid: 17016550
references.citation: J Clin Endocrinol Metab. 2011 Dec;96(12):3717-23
references.pmid: 21917863
references.citation: Eur J Endocrinol. 2007 Feb;156(2):181-6
references.pmid: 17287407
references.citation: Eur J Endocrinol. 2012 Sep;167(3):295-9
references.pmid: 22802423
references.citation: PLoS One. 2012;7(4):e34979
references.pmid: 22511976
references.citation: Int J Obes (Lond). 2012 Feb;36(2):320-4
references.pmid: 21610697
references.citation: Eur J Endocrinol. 2008 Feb;158(2):217-21
references.pmid: 18230829
references.citation: Circulation. 2012 Aug 28;126(9):1040-9
references.pmid: 22821943
references.citation: Arch Intern Med. 2005 Nov 28;165(21):2467-72
references.pmid: 16314542
references.citation: Thyroid. 2012 Sep;22(9):870-6
references.pmid: 22870927
references.citation: Eur J Endocrinol. 2010 Aug;163(2):273-8
references.pmid: 20516204